SEC 13F Intelligence

Managers / Q4 2024 · view latest →

P2 Capital Partners, LLC

CIK 0001406313 · 590 MADISON AVENUE, 25TH FLOOR, NEW YORK, NY, 10022 · (212) 508-5500

Reported Value
$589M
Q4 2024
Positions
11
Filings on Record
30
2019–present window
Filed
Feb 14, 2025
original filing

Summary

P2 Capital Partners, LLC reported $589M in U.S.-listed holdings across 11 positions for Q4 2024.

The portfolio is heavily concentrated: CBZ alone accounts for 25.1% of reported value.

Compared with Q3 2024, the fund opened 1 new position and exited 5.

Portfolio Metrics

Turnover
+9.2%
vs prior filed quarter
Top-10 Concentration
+97.5%
share of reported value
Largest Position
+25.1%
Cbiz
New / Exited
1 / 5
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $991MQ4 ’18Q1 ’19: $1.2BQ2 ’19: $1.3BQ3 ’19: $1.5BQ4 ’19: $1.4BQ4 ’19Q1 ’20: $836MQ2 ’20: $1.2BQ3 ’20: $1.3BQ4 ’20: $1.5BQ4 ’20Q1 ’21: $1.5BQ2 ’21: $1.3BQ3 ’21: $1.2BQ4 ’21: $1.3BQ4 ’21Q1 ’22: $1.1BQ2 ’22: $883MQ3 ’22: $810MQ4 ’22: $756MQ4 ’22Q1 ’23: $780MQ2 ’23: $859MQ3 ’23: $764MQ4 ’23: $909MQ4 ’23Q1 ’24: $846MQ2 ’24: $912MQ3 ’24: $876MQ4 ’24: $589MQ4 ’24Q1 ’25: $515MQ2 ’25: $522MQ3 ’25: $520MQ4 ’25: $390MQ4 ’25Q1 ’26: $210Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 96.0%Other: 4.0%
  • Common Stock · 96.0% · $565M
  • Other · 4.0% · $24M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
HSICHENRY SCHEIN INCNEW+583.3K583.3K+$40M$40M
OPCHOPTION CARE HEALTH INCSOLD OUT−1.95M0−$61M$0
MIRMIRION TECHNOLOGIES INCSOLD OUT−3.35M0−$37M$0
ENSGENSIGN GROUP INCSOLD OUT−230.0K0−$33M$0
SITESITEONE LANDSCAPE SUPPLY INCSOLD OUT−30.6K0−$5M$0
SHCSOTERA HEALTH COSOLD OUT−200.0K0−$3M$0
LIVANOVA PLCTRIMMED−539.2K510.8K−$32M$24M
FULFULLER H B COTRIMMED−271.9K339.4K−$26M$23M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2024

11 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CBZCBIZ INChistory →COM25.14%$148M1.81M
2ACHCACADIA HEALTHCARE COMPANY INhistory →COM14.78%$87M2.19M
3JBTJOHN BEAN TECHNOLOGIES CORPhistory →COM12.81%$75M593.6K
4BLKBBLACKBAUD INChistory →COM9.52%$56M758.2K
5IASINTEGRAL AD SCIENCE HLDNG COhistory →COM8.53%$50M4.81M
6TN1TENNANT COhistory →COM7.16%$42M517.1K
7HSICHENRY SCHEIN INChistory →COM6.86%$40M583.3K
8AVNTAVIENT CORPORATIONhistory →COM4.84%$28M696.9K
9LIVANOVA PLCSHS4.02%$24M510.8K
10FULFULLER H B COhistory →COM3.89%$23M339.4K
11ENOVENOVIS CORPORATIONhistory →COM2.46%$14M330.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$210M10May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$390M10Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$520M13Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$522M13Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$515M12May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$589M11Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$876M15Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$912M18Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$846M15May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$909M15Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$764M14Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$859M15Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$780M15May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$756M15Feb 23, 202313F-HRchanges · EDGAR ↗
Q3 2022$810M19Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$883M21Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.1B22May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$1.3B21Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$1.2B20Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.3B19Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.5B20May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.5B18Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.3B18Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.2B17Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$836M14May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.4B16Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$1.5B16Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.3B16Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.2B17May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$991M17Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.